1. Home
  2. TLRY vs PHAT Comparison

TLRY vs PHAT Comparison

Compare TLRY & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilray Brands Inc.

TLRY

Tilray Brands Inc.

HOLD

Current Price

$3.03

Market Cap

533.5M

Sector

Health Care

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$6.79

Market Cap

590.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLRY
PHAT
Founded
N/A
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.5M
590.6M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
TLRY
PHAT
Price
$3.03
$6.79
Analyst Decision
Buy
Buy
Analyst Count
10
12
Target Price
$5.89
★ $20.09
AVG Volume (30 Days)
★ 3.6M
1.2M
Earning Date
10-08-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.69
42.72
EPS
★ N/A
N/A
Revenue
N/A
★ $175,110,000.00
Revenue This Year
$20.15
$80.58
Revenue Next Year
$5.32
$56.62
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 216.93
52 Week Low
$0.77
$6.52
52 Week High
$15.70
$18.31

Technical Indicators

Market Signals
Indicator
TLRY
PHAT
Relative Strength Index (RSI) 23.02 38.36
Support Level N/A $6.52
Resistance Level $4.91 $9.74
Average True Range (ATR) 0.18 0.37
MACD -0.05 0.07
Stochastic Oscillator 2.58 22.50

Price Performance

Historical Comparison
TLRY
PHAT

About TLRY Tilray Brands Inc.

Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: